Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Skinvisible Inc SKVI

Consumer Defensive Household & Personal Products
Skinvisible, Inc., through its wholly owned subsidiary Skinvisible Pharmaceuticals Inc., is a pharmaceutical research and development (R&D) company. The Company is engaged in developing and patenting a polymer delivery system, Invisicare, and formulating over forty topical skin products. Its flagship product, Pivotal, is a patented polymer delivery system technology, Invisicare. Invisicare is a... see more

Recent & Breaking News (OTCQB:SKVI)

Skinvisible Announces Article Highlighting Its Proprietary Transdermal Obesity Formulation Development

Accesswire October 3, 2024

Promising Data on Transdermal Obesity Formulations Announced by Skinvisible

Accesswire July 11, 2024

Skinvisible Unveils Promising Data on Transdermal Obesity Formulations

Accesswire July 9, 2024

Skinvisible Expands Obesity Patent Application for Transdermal Delivery

Accesswire June 24, 2024

Skinvisible Submits Innovative Obesity Patent for Advanced Transdermal Treatment

Accesswire May 29, 2024

Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome

Accesswire February 14, 2024

Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New Drug

Accesswire June 6, 2022

Skinvisible Announces License Agreement

Accesswire February 13, 2020

Skinvisible Announces Worldwide License Agreement with Quoin Pharmaceuticals in Conjunction with Mutual Termination of Merger Agreement

Accesswire October 22, 2019

Skinvisible Provides Update on Proposed Merger with Quoin Pharmaceuticals

GlobeNewswire March 26, 2018

Skinvisible Announces Proposed Merger with Quoin Pharmaceuticals

Marketwired November 27, 2017

New Skinvisible, Inc. Subsidiary Signs Exclusive License Agreement to Distribute Its Topical Cannabis Products in the USA

Newsfile November 16, 2017

New Skinvisible, Inc. (SKVI) Subsidiary Signs Exclusive License Agreement to Distribute Its Topical Cannabis Products in the USA

Marketwired November 16, 2017

Skinvisible, Inc. (SKVI) Engages NetworkNewsWire for Corporate Communications Solutions

Marketwired October 17, 2017

Skinvisible and Canopy Growth Enter License Agreement

Marketwired September 28, 2017

Canopy Growth and Skinvisible Sign Definitive Agreement to Bring New Products to Market

Canada NewsWire September 28, 2017

Skinvisible Improves the Delivery of Cannabis with Patented Invisicare Technology

Marketwired July 7, 2017

Skinvisible Completes First Sale of DermSafe Hand Sanitizer in China

Accesswire June 6, 2017

Skinvisible Brings Patented Technology to the Topical and Transdermal Cannabis Industry

Accesswire February 21, 2017

Skinvisible Signs Global Licensing Agreement for Its Cannabis Products

Accesswire September 15, 2016